There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.

SNPX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.33%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Synaptogenix Insider Trading History Chart

Synaptogenix Share Price & Price History

^$4.75

▼ -0.16 (-3.26%)

As of 05/17/2024 01:00 AM ET

Days: 30 | 90 | 365

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

Synaptogenix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/16/2022	Daniel L. Alkon	Insider	Sell	787	$29.25	$23,019.75	1,421
12/16/2022	William S Singer	Director	Sell	1,080	$29.25	$31,590.00	1,320
6/14/2021	Daniel L. Alkon	Insider	Buy	400	$206.50	$82,600.00	459

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Secure Your Spot Now

SEC Filings (Institutional Ownership Changes) for Synaptogenix (NASDAQ:SNPX)

10.34% of Synaptogenix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Synaptogenix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/3/2023	Cannell & Co.	30,000	$35K	0.0%	-60.6%	0.413%
1/11/2023	Platform Technology Partners	25,138	$29K	0.0%	+56.8%	0.346%
8/12/2022	Ikarian Capital LLC	121,191	$0.61M	0.1%	-20.9%	1.772%
5/3/2022	Platform Technology Partners	16,032	$0.12M	0.1%	-25.0%	0.235%
2/14/2022	Diametric Capital LP	30,521	$0.26M	0.2%	-17.2%	0.457%
2/7/2022	Orion Capital Management LLC	4,000	$34K	0.0%	N/A	0.060%
2/1/2022	Platform Technology Partners	21,375	$0.18M	0.1%	-34.2%	0.320%
9/17/2021	Virtu Financial LLC	14,259	$0.14M	0.0%	N/A	0.232%
8/18/2021	Ikarian Capital LLC	300,000	$2.96M	0.2%	N/A	4.968%
8/17/2021	Worth Venture Partners LLC	73,909	$0.64M	0.2%	N/A	1.224%
8/17/2021	Boothbay Fund Management LLC	34,079	$0.34M	0.0%	N/A	0.564%
8/16/2021	Diametric Capital LP	21,901	$0.22M	0.2%	N/A	0.363%
8/12/2021	AIGH Capital Management LLC	316,945	$2.83M	0.5%	N/A	5.248%
8/10/2021	CM Management LLC	10,000	$99K	0.1%	N/A	0.166%
8/5/2021	Platform Technology Partners	32,500	$0.32M	0.1%	N/A	0.538%

Data available starting January 2016

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.

Today's Range

Now: $4.75

$4.75

$5.01

50 Day Range

MA: $4.71

$4.33

$5.39

52 Week Range

Now: $4.75

$3.53

$47.00

Volume

24,910 shs

Average Volume

56,792 shs

Market Capitalization

$5.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of Synaptogenix?: Synaptogenix's top insider investors include:
Daniel L Alkon (Insider)
William S Singer (Director)
Learn More about top insider investors at Synaptogenix.